pSivida forges development agreement with Pfizer, but does little to help its perilous financial situation
April 09, 2007 | Analyst Insight
Last week, Australian drug delivery technology developer pSivida announced that it had signed a deal with pharmaceutical giant Pfizer to jointly develop pSivida’s Medidur ocular implant technology, which included Pfizer...
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.